You are here

Home » Publications

Publications

A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.
Christensen KD, Uhlmann WR, J Roberts S, et al. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med. 2018;20(1):132-141. doi:10.1038/gim.2017.103.
Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia.
Wang S-H, Hsiao P-C, Yeh L-L, et al. Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia. Genes Brain Behav. 2018;17(1):49-55. doi:10.1111/gbb.12401.
Synaptic Targeting and Function of SAPAPs Mediated by Phosphorylation-Dependent Binding to PSD-95 MAGUKs.
Zhu J, Zhou Q, Shang Y, et al. Synaptic Targeting and Function of SAPAPs Mediated by Phosphorylation-Dependent Binding to PSD-95 MAGUKs. Cell Rep. 2017;21(13):3781-3793. doi:10.1016/j.celrep.2017.11.107.
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.
Landau DA, Sun C, Rosebrock D, et al. The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy. Nat Commun. 2017;8(1):2185. doi:10.1038/s41467-017-02329-y.
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.
Liu D, Abbosh P, Keliher D, et al. Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer. Nat Commun. 2017;8(1):2193. doi:10.1038/s41467-017-02320-7.
Sequence data and association statistics from 12,940 type 2 diabetes cases and controls.
Flannick J, Fuchsberger C, Mahajan A, et al. Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. Sci Data. 2017;4:170179. doi:10.1038/sdata.2017.179.
High-throughput Phenotyping of Lung Cancer Somatic Mutations.
Berger AH, Brooks AN, Wu X, et al. High-throughput Phenotyping of Lung Cancer Somatic Mutations. Cancer Cell. 2017;32(6):884. doi:10.1016/j.ccell.2017.11.008.
A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.
Zhou Y, Castonguay P, Sidhom E-H, et al. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models. Science. 2017;358(6368):1332-1336. doi:10.1126/science.aal4178.
The Human Cell Atlas.
Regev A, Teichmann SA, Lander ES, et al. The Human Cell Atlas. Elife. 2017;6. doi:10.7554/eLife.27041.
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.
Chen L, Alexe G, Dharia NV, et al. CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2. J Clin Invest. 2017. doi:10.1172/JCI90793.